Volume Alert - ACT 267.20 Actavis Inc $ACT Hit a high today of 269.11 Closing the day 10:30 at 267.20 -2.40 -0.89% With a day low of 264.02 and a total volume of 1,898,388.
ACT Recent Posts: http://investorshangout.com/Actavis-Inc-ACT-53105/
ACT Actavis Inc Recent Headline News
Mallinckrodt Earnings Beat But No New Guidance
at Investor's Business Daily - 1 hr 6 mins ago
Specialty drugmaker Mallinckrodt beat analysts' expectations handily in its fiscal Q4 report, but it didn't provide hoped-for guidance in the wake of an FDA decision that hits one of its best-selling drugs. Mallinckrodt (MNK) stock was down 4% in...
MNK: 85.09 (-3.71), JNJ: 108.39 (-0.44), ACT: 269.00 (-0.60), COV: 97.83 (-0.26)
Stock Market News for November 19, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - 2 hrs 38 mins ago
Rally in healthcare stocks and easing global growth worries boosted benchmarks to finish in the green on Tuesday
URBN: 29.17 (+0.38), AGN: 213.50 (+0.13), HD: 97.04 (+1.06), ACT: 269.00 (-0.60), GILD: 101.98 (-1.73), PFE: 30.34 (-0.25), COV: 97.83 (-0.26), ALXN: 194.12 (+1.75)
Critical Alerts For Gold Fields, Actavis, Trina Solar Limited, Alcoa and Herbalife Released By InvestorsObserver
PR Newswire - Wed Nov 19, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for GFI, ACT, TSL, AA and HLF.
HLF: 38.62 (+0.30), AA: 16.71 (-0.45), ACT: 269.00 (-0.60), GFI: 4.28 (-0.07), TSL: 10.59 (+0.45)
Cramer's Mad Money - PPG Industries Will Blow Right Through Its All-Time High (11/18/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Wed Nov 19, 4:30AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday November 18. CEO Interview: Chuck Bunch, PPG Industries (NYSE: PPG ) PPG Industries ( PPG ) has been a consistent performer. It has dominance in the...
AGN: 213.50 (+0.13), GPRO: 82.85 (-1.25), HD: 97.04 (+1.06), ACT: 269.00 (-0.60), BX: 32.78 (+0.17), S: 4.72 (-0.04), HAL: 47.89 (-0.65), M: 61.86 (+0.41), COP: 72.12 (+0.45), GPS: 39.48 (+0.13), BRK.B: 145.23 (-0.58), PPG: 210.19 (+1.69), BHI: 62.65 (-0.90)
Pharma ETFs In Focus On Allergan Takeover Deal
Zacks Funds - at Seeking Alpha - Tue Nov 18, 9:04PM CST
The healthcare space is witnessing 2014 as another banner year thanks to encouraging industry trends, solid corporate earnings and huge levels of merger and acquisition activities. The sector is clearly leading the broad market rally and this trend...
IHE: 148.03 (-0.58), AGN: 213.50 (+0.13), PPH: 65.39 (-0.18), ACT: 269.00 (-0.60), XPH: 111.00 (-0.31)
Jim Cramer's 'Mad Money' Recap: Why Running With the Bulls Is Profitable but Dangerous
at The Street - Tue Nov 18, 7:10PM CST
It's hard to be skeptical about high-flying stocks when the bulls are making money right now, Cramer says.
MMM: 158.38 (-1.77), AMZN: 327.41 (+2.48), JEC: 47.08 (-0.62), ACT: 269.00 (-0.60), HD: 97.04 (+1.06), BX: 32.78 (+0.17), DPLO: 24.53 (+0.52), UNH: 97.07 (-1.12), DECK: 94.07 (+1.87), COLM: 43.27 (+1.62), ALKS: 55.38 (+2.44), ADT: 35.26 (-0.11), CELG: 107.59 (+0.81), VE: 18.05 (+0.17), URBN: 29.17 (+0.38), AGN: 213.50 (+0.13), HLT: 25.52 (-0.09), AA: 16.71 (-0.45), RIG: 25.35 (-0.50), WMB: 55.30 (+0.76), PF: 32.56 (+0.08), PPG: 210.19 (+1.69), WPZ: 52.61 (+0.11)
Actavis'
at Investor's Business Daily - Tue Nov 18, 5:42PM CST
Actavis' (ACT) $66 bil takeover of Allergan (AGN) gets activist investor William Ackman's support, said Reuters. Ackman will reportedly withdraw a special shareholder meeting request at Allergan. Actavis shares jumped 8.7% to 269.60. Allergan rose 2%...
AGN: 213.50 (+0.13), ACT: 269.00 (-0.60)
Celldex Therapeutics Surges on Positive Rindopepimut Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 4:05PM CST
Celldex Therapeutics announced encouraging interim update from the phase II ReACT study evaluating the use of rindopepimut.
ACT: 269.00 (-0.60), CLDX: 19.27 (+1.55), ABBV: 65.69 (-0.36)
Vipshop, Jack in the Box Rise In After-Hours Trading
at Investor's Business Daily - Tue Nov 18, 4:04PM CST
Stocks finished higher Tuesday, with the Dow Jones industrial average and the S&P 500 making fresh all-time highs and the Nasdaq overcoming Monday's weakness with a 14 1/2-year high. Volume was higher than Monday on the NYSE and slightly lower on the...
AGN: 213.50 (+0.13), JACK: 75.39 (+3.89), ACT: 269.00 (-0.60), VIPS: 22.73 (-0.98)
Market News: Actavis Plc, SunEdison Inc, Halliburton Company
at The Street - Tue Nov 18, 3:54PM CST
Investors' confidence on the U.S. economy increased due to better-than-expected corporate earnings and economic data The stock markets in the United States rallied amid investors' speculation that...
ACT: 269.00 (-0.60), TERP: 32.00 (-0.75), SUNE: 21.40 (-0.08), HAL: 47.88 (-0.66), BHI: 62.65 (-0.90)
Stocks Hit New Milestones; BitAuto Rebounds
at Investor's Business Daily - Tue Nov 18, 3:17PM CST
Stocks reached new milestones Tuesday following a mixed performance in the prior session. The Nasdaq made back Monday's loss and then some as it rallied 0.7% to a 14-1/2-year high. The S&P 500 and the Dow Jones industrial average climbed 0.5% and...
AGN: 213.50 (+0.13), VRX: 141.16 (-0.78), ACT: 269.00 (-0.60), BITA: 91.26 (-2.73), BABA: 109.92 (-0.89)
Stock Market Today: Oil Slump Fuels S&P 500 to Fresh Record High
at The Street - Tue Nov 18, 3:09PM CST
Three cheers for the S&P 500 which closed the session at an all-time high for a fifth-consecutive session.
SPLS: 14.04 (+1.28), ACT: 269.00 (-0.60), HD: 97.04 (+1.06), MDT: 71.95 (-0.52), XOM: 95.15 (+0.28), AGN: 213.50 (+0.13), URBN: 29.17 (+0.38), TJX: 62.01 (+0.37), GILD: 101.98 (-1.73), TOT: 58.47 (+0.07), TGT: 72.68 (+5.17), LOW: 62.42 (+3.89), CVX: 116.07 (+0.60)
Zoetis 2015 Guidance Misses As Buyout Theories Abound
at Investor's Business Daily - Tue Nov 18, 2:15PM CST
Animal-health giant Zoetis (ZTS) offered 2015 guidance below the Street's consensus along with longer-term financial goals at its analyst day Tuesday. After a brief halt in trading for the early-afternoon announcement, the stock was down more than 1%...
AGN: 213.50 (+0.13), ZTS: 43.74 (-0.45), ABT: 43.60 (-0.10), ACT: 269.00 (-0.60), VRX: 141.16 (-0.78), PFE: 30.34 (-0.25)
Stock Movers: Why 4 Big Drug Stocks Are Rising Today
at Investor's Business Daily - Tue Nov 18, 1:38PM CST
Drugmakers clustered near the top of IBD's Stocks On The Move list Tuesday afternoon. Actavis (ACT), an Ireland-based maker of generic and branded drugs, shot up more than 7% in huge volume in Tuesday afternoon trading on the stock market today. That...
AGN: 213.50 (+0.13), VRX: 141.16 (-0.78), ACT: 269.00 (-0.60), TARO: 147.00 (-1.66), GILD: 101.99 (-1.72)
Stock Market Today: S&P 500 Rallies as Oil Falls Below $75 a Barrel
at The Street - Tue Nov 18, 1:23PM CST
The S&P 500 smashes its last intraday record high, moving higher after oil falls below $75 a barrel.
URBN: 29.17 (+0.38), AGN: 213.50 (+0.13), HD: 97.04 (+1.06), ACT: 269.00 (-0.60), TERP: 32.00 (-0.75), MDT: 71.95 (-0.52), GILD: 101.99 (-1.72), SUNE: 21.41 (-0.07), HIMX: 6.59 (+0.15), AAPL: 114.68 (-0.79), NOK: 7.77 (-0.16)
Stocks Hold Near Fresh Milestones; Actavis Hits New High
at Investor's Business Daily - Tue Nov 18, 12:33PM CST
Stocks were near their best levels of the session Tuesday afternoon amid news from Japan and a jump in homebuilder confidence. The Nasdaq rose 0.7%. Earlier, it touched a fresh 14-1/2-year high. The S&P 500 climbed 0.5% to an all-time high....
AGN: 213.50 (+0.13), VIPS: 22.73 (-0.98), VRX: 141.16 (-0.78), ACT: 269.00 (-0.60), HD: 97.04 (+1.06), BITA: 91.26 (-2.73)
Actavis Strikes $66 Billion Deal for Botox Maker Allergan - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Nov 18, 12:20PM CST
This acquisition will place Actavis among the top 10 pharma companies based on sales.
AGN: 213.50 (+0.13), BIIB: 303.93 (-1.63), ACT: 269.00 (-0.60), VRX: 141.16 (-0.78)
Pharma ETFs in Focus on Allergan Takeover Deal - ETF News And Commentary
Sweta Killa - ZACKS - Tue Nov 18, 12:00PM CST
Pharma ETFs could get further boost from Actavis and Allergan merger deal in the coming days.
IHE: 148.03 (-0.58), AGN: 213.50 (+0.13), VRX: 141.16 (-0.78), PPH: 65.39 (-0.18), ACT: 269.00 (-0.60), XPH: 111.00 (-0.31)
Teva wins Actonel patent appeal
Seeking Alpha - at Seeking Alpha - Tue Nov 18, 11:06AM CST
ACT: 269.00 (-0.60), MYL: 55.66 (-0.58), TEVA: 57.31 (+0.08)
ACT Recent Posts: http://investorshangout.com/Actavis-Inc-ACT-53105/
ACT Actavis Inc Recent Headline News
Mallinckrodt Earnings Beat But No New Guidance
at Investor's Business Daily - 1 hr 6 mins ago
Specialty drugmaker Mallinckrodt beat analysts' expectations handily in its fiscal Q4 report, but it didn't provide hoped-for guidance in the wake of an FDA decision that hits one of its best-selling drugs. Mallinckrodt (MNK) stock was down 4% in...
MNK: 85.09 (-3.71), JNJ: 108.39 (-0.44), ACT: 269.00 (-0.60), COV: 97.83 (-0.26)
Stock Market News for November 19, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - 2 hrs 38 mins ago
Rally in healthcare stocks and easing global growth worries boosted benchmarks to finish in the green on Tuesday
URBN: 29.17 (+0.38), AGN: 213.50 (+0.13), HD: 97.04 (+1.06), ACT: 269.00 (-0.60), GILD: 101.98 (-1.73), PFE: 30.34 (-0.25), COV: 97.83 (-0.26), ALXN: 194.12 (+1.75)
Critical Alerts For Gold Fields, Actavis, Trina Solar Limited, Alcoa and Herbalife Released By InvestorsObserver
PR Newswire - Wed Nov 19, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for GFI, ACT, TSL, AA and HLF.
HLF: 38.62 (+0.30), AA: 16.71 (-0.45), ACT: 269.00 (-0.60), GFI: 4.28 (-0.07), TSL: 10.59 (+0.45)
Cramer's Mad Money - PPG Industries Will Blow Right Through Its All-Time High (11/18/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Wed Nov 19, 4:30AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday November 18. CEO Interview: Chuck Bunch, PPG Industries (NYSE: PPG ) PPG Industries ( PPG ) has been a consistent performer. It has dominance in the...
AGN: 213.50 (+0.13), GPRO: 82.85 (-1.25), HD: 97.04 (+1.06), ACT: 269.00 (-0.60), BX: 32.78 (+0.17), S: 4.72 (-0.04), HAL: 47.89 (-0.65), M: 61.86 (+0.41), COP: 72.12 (+0.45), GPS: 39.48 (+0.13), BRK.B: 145.23 (-0.58), PPG: 210.19 (+1.69), BHI: 62.65 (-0.90)
Pharma ETFs In Focus On Allergan Takeover Deal
Zacks Funds - at Seeking Alpha - Tue Nov 18, 9:04PM CST
The healthcare space is witnessing 2014 as another banner year thanks to encouraging industry trends, solid corporate earnings and huge levels of merger and acquisition activities. The sector is clearly leading the broad market rally and this trend...
IHE: 148.03 (-0.58), AGN: 213.50 (+0.13), PPH: 65.39 (-0.18), ACT: 269.00 (-0.60), XPH: 111.00 (-0.31)
Jim Cramer's 'Mad Money' Recap: Why Running With the Bulls Is Profitable but Dangerous
at The Street - Tue Nov 18, 7:10PM CST
It's hard to be skeptical about high-flying stocks when the bulls are making money right now, Cramer says.
MMM: 158.38 (-1.77), AMZN: 327.41 (+2.48), JEC: 47.08 (-0.62), ACT: 269.00 (-0.60), HD: 97.04 (+1.06), BX: 32.78 (+0.17), DPLO: 24.53 (+0.52), UNH: 97.07 (-1.12), DECK: 94.07 (+1.87), COLM: 43.27 (+1.62), ALKS: 55.38 (+2.44), ADT: 35.26 (-0.11), CELG: 107.59 (+0.81), VE: 18.05 (+0.17), URBN: 29.17 (+0.38), AGN: 213.50 (+0.13), HLT: 25.52 (-0.09), AA: 16.71 (-0.45), RIG: 25.35 (-0.50), WMB: 55.30 (+0.76), PF: 32.56 (+0.08), PPG: 210.19 (+1.69), WPZ: 52.61 (+0.11)
Actavis'
at Investor's Business Daily - Tue Nov 18, 5:42PM CST
Actavis' (ACT) $66 bil takeover of Allergan (AGN) gets activist investor William Ackman's support, said Reuters. Ackman will reportedly withdraw a special shareholder meeting request at Allergan. Actavis shares jumped 8.7% to 269.60. Allergan rose 2%...
AGN: 213.50 (+0.13), ACT: 269.00 (-0.60)
Celldex Therapeutics Surges on Positive Rindopepimut Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 4:05PM CST
Celldex Therapeutics announced encouraging interim update from the phase II ReACT study evaluating the use of rindopepimut.
ACT: 269.00 (-0.60), CLDX: 19.27 (+1.55), ABBV: 65.69 (-0.36)
Vipshop, Jack in the Box Rise In After-Hours Trading
at Investor's Business Daily - Tue Nov 18, 4:04PM CST
Stocks finished higher Tuesday, with the Dow Jones industrial average and the S&P 500 making fresh all-time highs and the Nasdaq overcoming Monday's weakness with a 14 1/2-year high. Volume was higher than Monday on the NYSE and slightly lower on the...
AGN: 213.50 (+0.13), JACK: 75.39 (+3.89), ACT: 269.00 (-0.60), VIPS: 22.73 (-0.98)
Market News: Actavis Plc, SunEdison Inc, Halliburton Company
at The Street - Tue Nov 18, 3:54PM CST
Investors' confidence on the U.S. economy increased due to better-than-expected corporate earnings and economic data The stock markets in the United States rallied amid investors' speculation that...
ACT: 269.00 (-0.60), TERP: 32.00 (-0.75), SUNE: 21.40 (-0.08), HAL: 47.88 (-0.66), BHI: 62.65 (-0.90)
Stocks Hit New Milestones; BitAuto Rebounds
at Investor's Business Daily - Tue Nov 18, 3:17PM CST
Stocks reached new milestones Tuesday following a mixed performance in the prior session. The Nasdaq made back Monday's loss and then some as it rallied 0.7% to a 14-1/2-year high. The S&P 500 and the Dow Jones industrial average climbed 0.5% and...
AGN: 213.50 (+0.13), VRX: 141.16 (-0.78), ACT: 269.00 (-0.60), BITA: 91.26 (-2.73), BABA: 109.92 (-0.89)
Stock Market Today: Oil Slump Fuels S&P 500 to Fresh Record High
at The Street - Tue Nov 18, 3:09PM CST
Three cheers for the S&P 500 which closed the session at an all-time high for a fifth-consecutive session.
SPLS: 14.04 (+1.28), ACT: 269.00 (-0.60), HD: 97.04 (+1.06), MDT: 71.95 (-0.52), XOM: 95.15 (+0.28), AGN: 213.50 (+0.13), URBN: 29.17 (+0.38), TJX: 62.01 (+0.37), GILD: 101.98 (-1.73), TOT: 58.47 (+0.07), TGT: 72.68 (+5.17), LOW: 62.42 (+3.89), CVX: 116.07 (+0.60)
Zoetis 2015 Guidance Misses As Buyout Theories Abound
at Investor's Business Daily - Tue Nov 18, 2:15PM CST
Animal-health giant Zoetis (ZTS) offered 2015 guidance below the Street's consensus along with longer-term financial goals at its analyst day Tuesday. After a brief halt in trading for the early-afternoon announcement, the stock was down more than 1%...
AGN: 213.50 (+0.13), ZTS: 43.74 (-0.45), ABT: 43.60 (-0.10), ACT: 269.00 (-0.60), VRX: 141.16 (-0.78), PFE: 30.34 (-0.25)
Stock Movers: Why 4 Big Drug Stocks Are Rising Today
at Investor's Business Daily - Tue Nov 18, 1:38PM CST
Drugmakers clustered near the top of IBD's Stocks On The Move list Tuesday afternoon. Actavis (ACT), an Ireland-based maker of generic and branded drugs, shot up more than 7% in huge volume in Tuesday afternoon trading on the stock market today. That...
AGN: 213.50 (+0.13), VRX: 141.16 (-0.78), ACT: 269.00 (-0.60), TARO: 147.00 (-1.66), GILD: 101.99 (-1.72)
Stock Market Today: S&P 500 Rallies as Oil Falls Below $75 a Barrel
at The Street - Tue Nov 18, 1:23PM CST
The S&P 500 smashes its last intraday record high, moving higher after oil falls below $75 a barrel.
URBN: 29.17 (+0.38), AGN: 213.50 (+0.13), HD: 97.04 (+1.06), ACT: 269.00 (-0.60), TERP: 32.00 (-0.75), MDT: 71.95 (-0.52), GILD: 101.99 (-1.72), SUNE: 21.41 (-0.07), HIMX: 6.59 (+0.15), AAPL: 114.68 (-0.79), NOK: 7.77 (-0.16)
Stocks Hold Near Fresh Milestones; Actavis Hits New High
at Investor's Business Daily - Tue Nov 18, 12:33PM CST
Stocks were near their best levels of the session Tuesday afternoon amid news from Japan and a jump in homebuilder confidence. The Nasdaq rose 0.7%. Earlier, it touched a fresh 14-1/2-year high. The S&P 500 climbed 0.5% to an all-time high....
AGN: 213.50 (+0.13), VIPS: 22.73 (-0.98), VRX: 141.16 (-0.78), ACT: 269.00 (-0.60), HD: 97.04 (+1.06), BITA: 91.26 (-2.73)
Actavis Strikes $66 Billion Deal for Botox Maker Allergan - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Nov 18, 12:20PM CST
This acquisition will place Actavis among the top 10 pharma companies based on sales.
AGN: 213.50 (+0.13), BIIB: 303.93 (-1.63), ACT: 269.00 (-0.60), VRX: 141.16 (-0.78)
Pharma ETFs in Focus on Allergan Takeover Deal - ETF News And Commentary
Sweta Killa - ZACKS - Tue Nov 18, 12:00PM CST
Pharma ETFs could get further boost from Actavis and Allergan merger deal in the coming days.
IHE: 148.03 (-0.58), AGN: 213.50 (+0.13), VRX: 141.16 (-0.78), PPH: 65.39 (-0.18), ACT: 269.00 (-0.60), XPH: 111.00 (-0.31)
Teva wins Actonel patent appeal
Seeking Alpha - at Seeking Alpha - Tue Nov 18, 11:06AM CST
ACT: 269.00 (-0.60), MYL: 55.66 (-0.58), TEVA: 57.31 (+0.08)
